Action Merck - MRK

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

94,66

Prix Achat

Prix Vente

Volume échangé

12 681 127

93,45 Fourchette du Jour 94,875

81,04 Plage de 52 semaines 134,63

Cap du marché

239,115B

Clôture Veille

94,71

Ouverture

94,50

Dernière Transaction

94.64

Dernière heure de transaction

Volume financier

US$ 1 192 688 261

VWAP

94,0522

Volume moyen (3 m)

14 746 576

Actions en circulation

2 526 036 240

Rendement du Dividende

3.42%

Ratio Cours sur Bénéfices

13,96

Bénéfice par action (BPA)

6,78

Chiffre d'affairess

64,17B

Bénéfice net

17,12B

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vacci... Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States. Show more

Secteur

Pharmaceutical Preparations

Industrie

Pharmaceutical Preparations

Site Web

www.merck.com

Siège social

West Trenton, New Jersey, USA

Fondé

Merck and Co Inc est coté dans le secteur Pharmaceutical Preparations de la New York Stock Exchange avec le ticker MRK. Le dernier cours de clôture d'Merck était de US$94,71. Au cours de la dernière année, les actions de Merck ont été négociées dans une fourchette de prix de US$ 81,04 à US$ 134,63.

Merck compte actuellement 2 526 036 240 actions en circulation. La capitalisation boursière d'Merck est de US$239,24 milliard. Merck a un ratio cours/bénéfice (ratio PE) de 13.96.

Flux global

Haussier

Prime nette

64M

Calls / Puts

1 985,71%

Ach. / Vent.

132,14%

OTM / ITM

8,96%

Sweeps Ratio

0,00%

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action...

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK) Shareholders

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK...

Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRK

Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit...

Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Acceptance based on results from the KEYNOTE-689 trial: the first Phase 3 trial to demonstrate significant improvement in event-free survival in...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.4	0.424358158286	94.26	97.31	92.8575	19144149	94.64665443	CS
4	10.245	12.1364686371	84.415	97.31	81.04	17199562	90.66296872	CS
12	-4.1527	-4.2025974394	98.8127	102.97	81.04	14746576	92.87785674	CS
26	-21.14	-18.2556131261	115.8	119.38	81.04	12651585	98.70048329	CS
52	-26.74	-22.0263591433	121.4	134.63	81.04	10741262	109.23923639	CS
156	16.78	21.5459681561	77.88	134.63	77.31	9349515	104.66717275	CS
260	23.89	33.7572417691	70.77	134.63	65.25	10202050	92.65639054	CS

MRK - Frequently Asked Questions (FAQ)

What is the current Merck share price?

The current share price of Merck is US$ 94,66

How many Merck shares are in issue?

Merck has 2 526 036 240 shares in issue

What is the market cap of Merck?

The market capitalisation of Merck is USD 239,24B

What is the 1 year trading range for Merck share price?

Merck has traded in the range of US$ 81,04 to US$ 134,63 during the past year

What is the PE ratio of Merck?

The price to earnings ratio of Merck is 13,96

What is the cash to sales ratio of Merck?

The cash to sales ratio of Merck is 3,72

What is the reporting currency for Merck?

Merck reports financial results in USD

What is the latest annual turnover for Merck?

The latest annual turnover of Merck is USD 64,17B

What is the latest annual profit for Merck?

The latest annual profit of Merck is USD 17,12B

What is the registered address of Merck?

The registered address for Merck is 820 BEAR TAVERN ROAD, WEST TRENTON, NEW JERSEY, 08628 1021

What is the Merck website address?

The website address for Merck is www.merck.com

Which industry sector does Merck operate in?

Merck operates in the PHARMACEUTICAL PREPARATIONS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
QBTSD Wave Quantum Inc	US$ 10,16 (47,03%)	261,24M
RBRKRubrik Inc	US$ 70,59 (27,70%)	7,27M
DMDesktop Metal Inc	US$ 2,4793 (21,53%)	651,82k
PDPagerDuty Inc	US$ 18,41 (17,94%)	4,37M
IONQIonQ Inc	US$ 25,00 (16,99%)	37,8M
XPOFXponential Fitness Inc	US$ 7,46 (-38,45%)	6,97M
NEUENeuehealth Inc	US$ 5,09 (-23,17%)	242,23k
SOLEmeren Group Ltd	US$ 1,18 (-19,73%)	1,23M
SKLZSkillz Inc	US$ 4,39 (-14,09%)	329,45k
TLYSTillys Inc	US$ 2,44 (-7,58%)	309,92k
QBTSD Wave Quantum Inc	US$ 10,16 (47,03%)	261,24M
FFord Motor Company	US$ 9,72 (1,99%)	91,31M
BBAIBigBear ai Holdings Inc	US$ 3,525 (7,80%)	55,12M
NUNu Holdings Ltd	US$ 11,72 (9,02%)	53,74M
NIONIO Inc	US$ 4,895 (3,49%)	53,62M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Merck and Co Inc (MRK) Cours

Merck and Co Inc (MRK)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de Merck and Co Inc

Flux d'options Merck (MRK)

Flux global

Haussier

Prime nette

64M

Calls / Puts

1 985,71%

Ach. / Vent.

132,14%

OTM / ITM

8,96%

Sweeps Ratio

0,00%

MRK Dernières nouvelles

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK) Shareholders

Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRK

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK

Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Merck to Participate in the TD Cowen 45th Annual Health Care Conference

The Gross Law Firm Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK

Form 4 - Statement of changes in beneficial ownership of securities

Merck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Merck & Co., Inc.(MRK) Shareholders

Merck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - MRK

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Merck Lawsuit - MRK

Shareholders that lost money on Merck & Co., Inc.(MRK) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Merck to Participate in the TD Cowen 45th Annual Health Care Conference

MRK - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités